Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.[Erratum for BMC Neurol. 2016 Jun 9;16:89. doi: 10.1186/s12883-016-0609-0.; PMID: 27276999] 

 -  2016 
<br/><br/>Available online from MWHC library: 2001 - present 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>1471-2377 
<br/><br/><label>Subjects--Topical Terms: </label><br/>IN PROCESS -- NOT YET INDEXED
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar National Rehabilitation Network
<br/><br/><label>Index Terms--Function: </label><br/>Published Erratum